ARROWHEAD PHARMACEUTICALS IN's ticker is and the CUSIP is 04280A950. A total of 4 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $228,395 | -70.9% | 8,500 | -61.4% | 0.00% | -66.7% |
| Q2 2023 | $784,520 | +836.0% | 22,000 | +566.7% | 0.00% | – |
| Q1 2023 | $83,820 | -94.9% | 3,300 | -91.8% | 0.00% | -100.0% |
| Q4 2022 | $1,630,512 | +16.4% | 40,200 | -5.2% | 0.00% | +33.3% |
| Q3 2022 | $1,401,000 | -11.6% | 42,400 | -5.8% | 0.00% | +50.0% |
| Q2 2022 | $1,584,000 | -49.0% | 45,000 | -33.3% | 0.00% | -33.3% |
| Q1 2022 | $3,104,000 | -32.2% | 67,500 | -2.2% | 0.00% | -25.0% |
| Q4 2021 | $4,575,000 | +80.5% | 69,000 | +70.0% | 0.00% | +33.3% |
| Q3 2021 | $2,535,000 | -21.9% | 40,600 | +3.6% | 0.00% | -25.0% |
| Q2 2021 | $3,247,000 | +130.0% | 39,200 | +84.0% | 0.00% | +100.0% |
| Q1 2021 | $1,412,000 | -59.3% | 21,300 | -52.9% | 0.00% | -66.7% |
| Q4 2020 | $3,468,000 | +193.9% | 45,200 | +65.0% | 0.01% | +50.0% |
| Q3 2020 | $1,180,000 | -41.9% | 27,400 | -41.7% | 0.00% | -55.6% |
| Q2 2020 | $2,030,000 | -2.5% | 47,000 | -35.1% | 0.01% | -47.1% |
| Q1 2020 | $2,083,000 | -65.4% | 72,400 | -23.6% | 0.02% | -58.5% |
| Q4 2019 | $6,013,000 | +785.6% | 94,800 | +293.4% | 0.04% | +720.0% |
| Q3 2019 | $679,000 | -70.2% | 24,100 | -72.0% | 0.01% | -76.2% |
| Q2 2019 | $2,282,000 | +3069.4% | 86,100 | +2107.7% | 0.02% | +2000.0% |
| Q1 2019 | $72,000 | -94.2% | 3,900 | -96.1% | 0.00% | -90.9% |
| Q4 2018 | $1,247,000 | +89.2% | 100,400 | +191.9% | 0.01% | +120.0% |
| Q3 2018 | $659,000 | -7.6% | 34,400 | -34.4% | 0.01% | -16.7% |
| Q2 2018 | $713,000 | -6.8% | 52,400 | -50.6% | 0.01% | -25.0% |
| Q1 2018 | $765,000 | +74.7% | 106,100 | -10.8% | 0.01% | +166.7% |
| Q4 2017 | $438,000 | -0.9% | 118,900 | +16.6% | 0.00% | -25.0% |
| Q3 2017 | $442,000 | +166.3% | 102,000 | -0.3% | 0.00% | +100.0% |
| Q2 2017 | $166,000 | -8.3% | 102,300 | +4.6% | 0.00% | 0.0% |
| Q1 2017 | $181,000 | +64.5% | 97,800 | +38.3% | 0.00% | +100.0% |
| Q4 2016 | $110,000 | -84.2% | 70,700 | -25.5% | 0.00% | -87.5% |
| Q3 2016 | $698,000 | +328.2% | 94,900 | +210.1% | 0.01% | +300.0% |
| Q2 2016 | $163,000 | – | 30,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 9,100 | $231,140 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,300 | $83,820 | 0.00% |
| SIMPLEX TRADING, LLC | 7,800 | $198 | 0.00% |